ICM
QDEL icon

Invenomic Capital Management’s QuidelOrtho QDEL Stock Holding History

Invenomic Capital Management’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Buy
+76,267
New +$1.87M 0.06% 138
2024
Q1 		– Sell
-503,991
Closed -$37.1M – 182
2023
Q4 		$37.1M Buy
+503,991
New +$34.1M 1.69% 15
2023
Q3 		– Sell
-38,218
Closed -$3.17M – 161
2023
Q2 		$3.17M Sell
38,218
-506
-1% -$44.3K 0.16% 105
2023
Q1 		$3.45M Buy
38,724
+891
+2% +$77.5K 0.19% 110
2022
Q4 		$3.24M Buy
37,833
+24,363
+181% +$2.06M 0.22% 106
2022
Q3 		$963K Buy
+13,470
New +$1.21M 0.08% 141

Other funds holding QDEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Invenomic Capital Management's QDEL Position: Q1 2026 in Review

Invenomic Capital Management opened a new position in QuidelOrtho (QDEL) in Q1 2026: 76,267 shares worth $1.25M. The stake represents 0.06% of the portfolio and ranks #138 among its holdings. This is a return to the name: Invenomic Capital Management previously reported a position in QDEL as recently as Q4 2023.

Invenomic Capital Management first reported a position in QDEL in Q3 2022 and has held it in 6 quarters since. The position peaked at $37.1M in Q4 2023. 237 funds tracked by Wall St. Rank hold QDEL as of Q1 2026.

  • Invenomic Capital Management held 76,267 shares of QuidelOrtho worth $1.25M as of Q1 2026.
  • QuidelOrtho was a new Invenomic Capital Management position in Q1 2026.
  • QuidelOrtho made up 0.06% of Invenomic Capital Management's portfolio in Q1 2026, its #138 holding.
  • Invenomic Capital Management first reported a position in QuidelOrtho in Q3 2022 and has held it in 6 quarters since.
  • Invenomic Capital Management's QuidelOrtho position peaked at $37.1M in Q4 2023.
  • 237 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.